Filing Details
- Accession Number:
- 0001104659-25-014860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-18 18:44:32
- Reporting Period:
- 2025-02-09
- Filing Date:
- 2025-02-18
- Accepted Time:
- 2025-02-18 18:44:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609550 | Inspire Medical Systems Inc. | INSP | Surgical & Medical Instruments & Apparatus (3841) | 261377674 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1737127 | Randy Ban | C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-09 | 314 | $182.15 | 2,767 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2025-02-13 | 5,076 | $0.00 | 7,843 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-02-13 | 25,000 | $67.63 | 32,843 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-13 | 2,500 | $178.54 | 30,343 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 1,000 | $179.41 | 29,343 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 1,330 | $180.79 | 28,013 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 3,770 | $181.90 | 24,243 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 3,242 | $182.90 | 21,001 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 2,541 | $183.79 | 18,460 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 3,452 | $184.81 | 15,008 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 3,824 | $185.84 | 11,184 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 3,341 | $186.96 | 7,843 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 584 | $187.66 | 7,259 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-13 | 25,000 | $0.00 | 25,000 | $67.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-07-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 167 | Indirect | Held by son |
| Common Stock | 166 | Indirect | Held by daughter |
Footnotes
- Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.
- Includes 25 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2024.
- Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.08 to $178.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.12 to $179.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.29 to $181.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.30 to $182.26. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.30 to $183.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.31 to $184.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.33 to $185.31. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.35 to $186.32. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.35 to $187.29. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Fully vested and exercisable.
Billionaire Hedge Funds
